Adicet Bio Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
Others were interested in
See all stocksFrequently asked questions
To buy Adicet Bio Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Adicet Bio Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Adicet Bio Inc. is ACET:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Adicet Bio Inc. has its primary listing on NASDAQ. You can trade Adicet Bio Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Adicet Bio Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Adicet Bio Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Adicet Bio Inc..